OUR TEAM
FOUNDERS
BOARD OF DIRECTORS
Dr. Antonius Schuh
Chairman Of The Board Of Directors
Dr. Yafit Stark
Director, Regulatory And Clinical Advisor
Tomer Goldberg
Vice President, Managing Director Harel Technology Investments at Harel Insurance & Finance
Ran Achituv
Entr'ee Capital General Partner
Helena Bond
Investment Officer
Non-voting observer on behalf of the EIC Fund
Eyal Dior
Founder & Managing Partner at Tal Ventures
Anat Tsour Segal
Board Member
Xenia Venture Capital
SCIENTIFIC ADVISORY
Prof. Roger D. Kornberg
Advisory
Dr. Lynn L. Silver
Microbiology Development Advisory
CLINICAL ADVISORY
Prof. Yehuda Carmeli, MD
Medical Advisory
Keith A. Rodvold, Pharm.D., FCCP, FIDSA
Clinical Advisory
Keith Kaye, MD, MPH
CLINICAL ADVISORY
OMNIX TEAM
Lihi Elyahu BA
VP Operations & Human Resources
Bella Shusterman MSc Pharm
VP Clinical Development
Shira Mandel MSc
VP Research & Discovery
Noa Nur-Maymon BSc Med, Biomed MBA
Director of Translational Research & IP Strategy
Jonathan Zazoun PharmD PhD
Head of CMC and Non-Dilutive Funding
Tamar Shachar BPharm, MSc
VP Strategy and Drug Development
Ofra Barchad-Avitzur, PhD
Senior Director of Clinical Affairs
Shelly Maximov BSc Eng, Data Science MBA
Director of Preclinical Development & Regulation
Elital Chass-Maurice MSc
Director of Clinical Operation
Orel Mayost Lev-Ari MSc
Research Associate
Inbal Doron, M.Sc
Research Associate
Ori Heyman PhD
Scientific Manager of In Vivo Research
Amir Ben-Dror BSc Eng
Project Manager
Meirav Belo
Office Manager
Deborah Mimoun, B.Sc.
Clinical Operations Associate